0,897  0,003  AR expression inhibitor
0,895  0,002  CTGF expression inhibitor
0,875  0,003  UGT1A6 substrate
0,864  0,002  Antimutagenic
0,866  0,004  Caspase 9 stimulant
0,852  0,004  CYP1A2 substrate
0,847  0,003  UGT1A9 substrate
0,843  0,004  Free radical scavenger
0,833  0,004  CYP1A2 inhibitor
0,833  0,004  Antioxidant
0,818  0,002  Cystathionine beta-synthase inhibitor
0,827  0,013  Apoptosis agonist
0,805  0,004  Carcinogenic, group 3
0,795  0,007  15-Lipoxygenase inhibitor
0,785  0,004  Cardioprotectant
0,779  0,002  Peroxidase inhibitor
0,780  0,005  12-Lipoxygenase inhibitor
0,777  0,003  UGT1A3 substrate
0,773  0,004  UDP-glucuronosyltransferase substrate
0,768  0,004  NOS2 expression inhibitor
0,769  0,006  Aryl hydrocarbon receptor agonist
0,763  0,004  NOS3 expression inhibitor
0,745  0,004  UGT1A1 substrate
0,741  0,011  TNF expression inhibitor
0,722  0,004  Genotoxic
0,726  0,008  Chemoprotective
0,721  0,007  Aldehyde oxidase inhibitor
0,713  0,003  GABA C receptor rho-3 antagonist
0,696  0,003  Interleukin 4 antagonist
0,694  0,005  Histamine release inhibitor
0,683  0,002  UGT2B15 substrate
0,674  0,001  Creatine kinase inhibitor
0,683  0,014  CYP2C9 substrate
0,695  0,035  Alpha-glucosidase inhibitor
0,670  0,013  Carcinogenic
0,652  0,007  Caspase 3 stimulant
0,674  0,036  Antiinflammatory
0,641  0,004  NOS3 expression enhancer
0,648  0,014  Prostate cancer treatment
0,650  0,018  Antileukemic
0,657  0,026  Antineoplastic (breast cancer)
0,636  0,008  Lipoxygenase inhibitor
0,630  0,007  Amyloid beta aggregation inhibitor
0,617  0,003  NADPH oxidase inhibitor
0,623  0,012  Mutagenic
0,615  0,008  CYP2C19 inhibitor
0,607  0,002  Antihemorrhagic
0,608  0,010  CYP2C9 inhibitor
0,610  0,014  Radioprotector
0,592  0,004  Breast cancer-resistant protein inhibitor
0,589  0,003  Carbonic anhydrase III inhibitor
0,591  0,005  Antihypertriglyceridemic
0,594  0,012  5 Hydroxytryptamine release inhibitor
0,589  0,011  Apoptosis antagonist
0,585  0,009  Antiprotozoal (Leishmania)
0,584  0,010  Ulceration
0,601  0,030  Antineoplastic (lung cancer)
0,577  0,007  Vascular (periferal) disease treatment
0,576  0,008  Superoxide dismutase inhibitor
0,570  0,003  SULT1A3 substrate
0,572  0,006  Antihypoxic
0,576  0,014  Cytostatic
0,592  0,032  Transcription factor NF kappa B inhibitor
0,573  0,015  Antineoplastic (cervical cancer)
0,571  0,015  Chemopreventive
0,561  0,005  P-glycoprotein inhibitor
0,564  0,009  Hypoxia-inducible factor 1 alpha inhibitor
0,556  0,005  Dual specificity phosphatase inhibitor
0,554  0,005  MAO A inhibitor
0,547  0,006  MAO inhibitor
0,567  0,030  Prostaglandin dehydrogenase inhibitor
0,568  0,032  CYP3A4 substrate
0,551  0,016  Proliferative diseases treatment
0,537  0,005  Amylase inhibitor
0,537  0,006  Skin whitener
0,537  0,007  ICAM1 expression inhibitor
0,528  0,004  Xanthine oxidase inhibitor
0,530  0,005  Dual specificity phosphatase 3 inhibitor
0,529  0,006  Topoisomerase II inhibitor
0,529  0,007  Monophenol monooxygenase inhibitor
0,528  0,007  Pyruvate kinase inhibitor
0,519  0,004  Pneumotoxic
0,517  0,004  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,514  0,002  Antihelmintic (Trematoda)
0,514  0,010  RNA-directed DNA polymerase inhibitor
0,504  0,002  NAD(P)H dehydrogenase (quinone) inhibitor
0,518  0,018  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,526  0,026  Antipruritic, allergic
0,503  0,003  Carbonic anhydrase VI inhibitor
0,510  0,011  Vasodilator
0,510  0,014  Hypoglycemic
0,500  0,005  Lipid peroxidase inhibitor
0,524  0,036  GST A substrate
0,497  0,016  Nitric oxide antagonist
0,475  0,004  Topoisomerase II alpha inhibitor
0,488  0,024  Hepatic disorders treatment
0,499  0,036  Antineoplastic (colorectal cancer)
0,462  0,005  Proto-oncogene tyrosine-protein kinase Yes inhibitor
0,473  0,017  Antiparasitic
0,485  0,030  5 Hydroxytryptamine release stimulant
0,483  0,036  Antineoplastic (colon cancer)
0,448  0,007  5 Hydroxytryptamine uptake stimulant
0,472  0,032  Bone diseases treatment
0,444  0,006  Protein-tyrosine phosphatase inhibitor
0,479  0,042  Antiprotozoal
0,440  0,004  Telomerase inhibitor
0,439  0,005  Chelator
0,465  0,033  Streptokinase A inhibitor
0,444  0,013  Antihelmintic
0,478  0,047  Antibacterial
0,449  0,020  Antiprotozoal (Trypanosoma)
0,455  0,026  Antineoplastic (glioma)
0,455  0,027  Antiosteoporotic
0,450  0,023  Vasodilator, coronary
0,421  0,008  DNA methyltransferase I inhibitor
0,451  0,038  Teratogen
0,421  0,010  Antihypotensive
0,425  0,014  Transcription factor STAT inhibitor
0,442  0,032  Spasmolytic
0,420  0,012  Hepatoprotectant
0,413  0,005  M18 aspartyl aminopeptidase inhibitor
0,411  0,004  Carbonic anhydrase XIII inhibitor
0,429  0,022  Tumour necrosis factor alpha release inhibitor
0,421  0,018  Myocardial infarction treatment
0,422  0,020  Antineoplastic (liver cancer)
0,405  0,005  Gout treatment
0,407  0,011  GST M1-1 substrate
0,410  0,014  UGT1A4 substrate
0,424  0,033  Antineoplastic (pancreatic cancer)
0,426  0,039  Antihypercholesterolemic
0,424  0,038  CYP2C19 substrate
0,422  0,036  Antineoplastic (melanoma)
0,397  0,014  Non-steroidal antiinflammatory agent
0,386  0,004  Nitric-oxide synthase stimulant
0,421  0,039  FMO1 substrate
0,387  0,005  5-Lipoxygenase inhibitor
0,408  0,027  DNA damaging
0,402  0,021  Antineoplastic (osteosarcoma)
0,408  0,029  UGT2B4 substrate
0,381  0,003  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,390  0,012  DNA methylase inhibitor
0,388  0,013  Melanin inhibitor
0,378  0,008  Sulfotransferase substrate
0,373  0,007  CYP2B6 inhibitor
0,367  0,004  GABA C receptor rho-2 antagonist
0,403  0,042  Embryotoxic
0,371  0,010  Protein kinase stimulant
0,375  0,015  Antiseptic
0,365  0,009  MAO B inhibitor
0,385  0,029  Cardiodepressant
0,385  0,030  Antineoplastic (glioblastoma multiforme)
0,387  0,034  Sensitization
0,355  0,004  Aldose reductase inhibitor
0,451  0,101  DNA polymerase beta inhibitor
0,448  0,098  DNA directed DNA polymerase inhibitor
0,357  0,009  Amyloid beta precursor protein antagonist
0,392  0,046  Antineoplastic (ovarian cancer)
0,349  0,004  VEGF expression inhibitor
0,349  0,005  Estrogen receptor beta antagonist
0,353  0,009  Acetylcholinesterase inhibitor
0,370  0,026  Antineoplastic (small cell lung cancer)
0,345  0,003  Multidrug resistance-associated protein 1 inhibitor
0,374  0,034  Cardiovascular analeptic
0,344  0,007  Carcinogenic, group 1
0,371  0,034  Antipyretic
0,342  0,004  HIV-1 integrase (3'-Processing) inhibitor
0,370  0,034  Antiamyloidogenic
0,339  0,004  HIV-1 integrase (Strand Transfer) inhibitor
0,379  0,048  CYP2D6 substrate
0,365  0,040  Antineoplastic (non-small cell lung cancer)
0,341  0,017  Mcl-1 antagonist
0,329  0,005  Alcohol dehydrogenase inhibitor
0,330  0,006  Carbonic anhydrase XV inhibitor
0,355  0,031  Angiogenesis stimulant
0,327  0,004  SULT1A1 substrate
0,363  0,041  Cytotoxic
0,380  0,059  Antiprotozoal (Plasmodium)
0,352  0,035  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,329  0,012  Antidote
0,314  0,002  D-Ala-D-Ala ligase inhibitor
0,320  0,010  Alkaline phosphatase inhibitor
0,315  0,005  Uric acid excretion stimulant
0,316  0,009  Protein-tyrosine phosphatase 1B inhibitor
0,362  0,057  Antifungal
0,309  0,004  Histone deacetylase SIRT1 stimulant
0,309  0,004  Histone deacetylase stimulant
0,308  0,003  Xanthine dehydrogenase inhibitor
0,314  0,010  Protein kinase (CK2) alpha inhibitor
0,325  0,023  Tyrosine 3 hydroxylase inhibitor
0,321  0,019  Antineoplastic (squamous cell carcinoma)
0,324  0,022  UGT2B7 substrate
0,302  0,004  Transcription factor STAT6 inhibitor
0,312  0,015  Neurotrophic factor enhancer
0,337  0,043  Radiosensitizer
0,389  0,097  Cyclophilin D inhibitor
0,389  0,097  Antidiabetic
0,297  0,005  Gastritis treatment
0,297  0,006  Estrogen antagonist
0,322  0,032  Antineoplastic enhancer
0,364  0,079  Immunosuppressant
0,337  0,058  CYP3A4 inhibitor
0,288  0,013  Succinate dehydrogenase inhibitor
0,304  0,029  Antiviral (Influenza)
0,335  0,060  Antiischemic
0,302  0,029  MAP-kinase-activated kinase 5 inhibitor
0,341  0,068  Antithrombotic
0,316  0,047  Dyrk kinase inhibitor
0,331  0,062  Respiratory analeptic
0,281  0,015  Glutathione S-transferase substrate
0,269  0,003  Fatty acid synthase inhibitor
0,275  0,011  Carcinogenic, group 2B
0,275  0,013  LDLR expression enhancer
0,274  0,015  UGT2B9 substrate
0,300  0,044  Antineoplastic (bladder cancer)
0,275  0,019  Heat shock protein 90 alpha antagonist
0,276  0,022  Tubulin antagonist
0,303  0,050  Antineoplastic (renal cancer)
0,368  0,115  Alzheimer's disease treatment
0,251  0,004  CDC25A inhibitor
0,270  0,024  Cholinergic
0,315  0,069  Antineoplastic (brain cancer)
0,291  0,046  Antineoplastic (sarcoma)
0,261  0,018  Insulin secretagoues
0,250  0,007  Antirickettsial
0,249  0,007  AMP-activated protein kinase stimulant
0,253  0,011  Protein kinase (CK2) inhibitor
0,261  0,027  Tumour necrosis factor antagonist
0,236  0,005  GABA C receptor rho-1 antagonist
0,273  0,042  Platelet adhesion inhibitor
0,251  0,021  Heat shock protein 90 antagonist
0,234  0,004  Heat shock protein 70 antagonist
0,234  0,005  Cyclin B3 inhibitor
0,236  0,008  GABA C receptor antagonist
0,236  0,007  Photosensitizer
0,280  0,053  Interleukin antagonist
0,231  0,004  DOPA decarboxylase inhibitor
0,291  0,064  Huntington's disease treatment
0,250  0,024  Cytokine production inhibitor
0,317  0,094  Stroke treatment
0,242  0,019  Aldehyde dehydrogenase inhibitor
0,228  0,006  T cell inhibitor
0,254  0,033  Antipruritic, non-allergic
0,229  0,009  Protein kinase C zeta inhibitor
0,224  0,004  Carbonic anhydrase VII inhibitor
0,242  0,023  Cyclooxygenase 1 inhibitor
0,237  0,019  Topoisomerase I inhibitor
0,306  0,090  Thyroid hormone antagonist
0,235  0,019  Antiviral (Ebola)
0,218  0,005  Myeloperoxidase inhibitor
0,249  0,035  Insulin sensitizer
0,218  0,004  CDC25B inhibitor
0,219  0,006  Macrophage migration inhibitory factor inhibitor
0,240  0,028  Cyclooxygenase inhibitor
0,222  0,010  Beta glucuronidase inhibitor
0,252  0,041  Muscle relaxant
0,241  0,032  Antineoplastic (carcinoma)
0,215  0,007  Estrogen receptor alpha antagonist
0,211  0,005  SULT1E1 substrate
0,217  0,011  Histidine decarboxylase inhibitor
0,212  0,009  HIV-1 integrase (Overall Integration) inhibitor
0,250  0,047  VCAM1 expression inhibitor
0,227  0,025  Hemostatic
0,207  0,006  Carbonic anhydrase V inhibitor
0,292  0,092  Thyroid hormone beta antagonist
0,277  0,079  FMO3 substrate
0,296  0,099  Vasodilator, peripheral
0,255  0,058  Antiulcerative
0,211  0,015  Cyclooxygenase 3 inhibitor
0,282  0,087  Analeptic
0,219  0,025  UGT2B10 substrate
0,215  0,023  Mannose-6-phosphate isomerase inhibitor
0,218  0,026  Antiprotozoal (Coccidial)
0,210  0,019  Toll-Like receptor 2 antagonist
0,319  0,128  Antiparkinsonian
0,199  0,009  Aromatase inhibitor
0,194  0,005  Estradiol 17 beta-dehydrogenase inhibitor
0,196  0,009  Electron transport complex I inhibitor
0,201  0,016  UGT2B1 substrate
0,225  0,043  Antiviral (Hepatitis)
0,321  0,140  Calcium channel L-type activator
0,208  0,029  Cyclooxygenase 2 inhibitor
0,183  0,004  Aryl hydrocarbon receptor antagonist
0,186  0,009  Estrogen agonist
0,199  0,022  Butyrylcholinesterase inhibitor
0,182  0,005  Thioredoxin reductase inhibitor
0,183  0,006  Carbonic anhydrase VA inhibitor
0,212  0,035  Antiviral (Hepatitis C)
0,198  0,023  CF transmembrane conductance regulator agonist
0,193  0,018  Coagulant
0,177  0,002  Dopamine D5 agonist
0,181  0,007  Interleukin 5 antagonist
0,204  0,030  Arachidonic acid antagonist
0,210  0,038  Skeletal muscle relaxant
0,185  0,014  Antineoplastic (uterine cancer)
0,187  0,017  Potassium channel (Ca-activated) activator
0,172  0,006  HIV-1 integrase inhibitor
0,250  0,083  Transcription factor STAT3 inhibitor
0,210  0,046  Antineoplastic (gastric cancer)
0,199  0,034  Alpha-N-acetylglucosaminidase inhibitor
0,199  0,037  Phobic disorders treatment
0,176  0,017  Androgen antagonist
0,177  0,017  Papain-like protease (SARS coronavirus) inhibitor
0,169  0,009  Antiviral (Coronavirus)
0,169  0,009  Antiviral (SARS coronavirus)
0,236  0,077  DNA synthesis inhibitor
0,242  0,083  5 Hydroxytryptamine 1E antagonist
0,175  0,017  Antiviral (Influenza B)
0,252  0,094  Insulysin inhibitor
0,204  0,046  Acaricide
0,182  0,024  Antineoplastic antibiotic
0,200  0,044  Phospholipase C inhibitor
0,185  0,029  GST P1-1 substrate
0,200  0,044  Antiviral (Influenza A)
0,172  0,017  DNA repair enzyme inhibitor
0,166  0,013  CYP2A6 inhibitor
0,181  0,028  Antiprotozoal (Trichomonas)
0,226  0,076  Antineoplastic (lymphoma)
0,156  0,007  Estrogen receptor beta agonist
0,189  0,039  Bone formation stimulant
0,200  0,052  3C-like protease (Human coronavirus) inhibitor
0,168  0,021  Antihelmintic (Fasciola)
0,158  0,011  Postmenopausal disorders treatment
0,217  0,071  Psychostimulant
0,158  0,014  Thioredoxin inhibitor
0,166  0,024  UDP-glucose 4-epimerase inhibitor
0,182  0,039  Antifungal enhancer
0,225  0,083  Antineoplastic (lymphocytic leukemia)
0,160  0,019  Urease inhibitor
0,242  0,102  Antineoplastic (multiple myeloma)
0,175  0,035  Alkylator
0,147  0,008  Antidote, heavy metal
0,172  0,033  Adenylate cyclase stimulant
0,224  0,091  Antidiabetic symptomatic
0,229  0,097  Flavin-containing monooxygenase substrate
0,158  0,026  Ca2+-transporting ATPase inhibitor
0,151  0,020  Antifungal (Pneumocystis)
0,243  0,114  Antimycobacterial
0,140  0,012  Lipase inhibitor
0,141  0,016  Antiviral (Rhinovirus)
0,211  0,086  Cyclic AMP phosphodiesterase inhibitor
0,175  0,050  Antidiarrheal
0,175  0,050  Glycogen synthase kinase-3 alpha inhibitor
0,213  0,089  Antiviral (West Nile virus)
0,130  0,007  CD45 antagonist
0,140  0,017  Antidote, mercury
0,147  0,026  Sphingomyelinase inhibitor
0,138  0,017  Interleukin 12 antagonist
0,180  0,059  Aldehyde oxidase substrate
0,144  0,024  Antispirochetal
0,194  0,074  5 Hydroxytryptamine 3E antagonist
0,133  0,014  Potassium channel large-conductance Ca-activated activator
0,177  0,059  Antiviral (Herpes)
0,138  0,021  ABCA1 expression enhancer
0,193  0,079  Histone acetyltransferase inhibitor
0,137  0,023  Porphobilinogen synthase inhibitor
0,220  0,109  Immunostimulant
0,136  0,025  Actinic keratosis treatment
0,124  0,012  Alpha tubulin antagonist
0,116  0,005  Glutamate (mGluR7) antagonist
0,124  0,013  Alcohol oxidase inhibitor
0,155  0,045  Antihyperlipoproteinemic
0,241  0,132  Cholesterol antagonist
0,119  0,010  Neuraminidase inhibitor
0,126  0,017  3C-Like protease (SARS coronavirus) inhibitor
0,126  0,016  Beta tubulin antagonist
0,197  0,088  Antialcoholic
0,125  0,016  Carbonic anhydrase XII inhibitor
0,220  0,111  Antituberculosic
0,145  0,036  GABA C receptor agonist
0,168  0,059  Hexokinase inhibitor
0,120  0,012  Neuraminidase (influenza) inhibitor
0,167  0,059  Hair growth stimulant
0,148  0,043  DNA intercalator
0,141  0,037  TRPA1 agonist
0,106  0,004  Protein kinase (CK2) beta inhibitor
0,129  0,027  UGT2B11 substrate
0,143  0,040  Excitatory amino acid transporter EAAC1 inhibitor
0,173  0,072  Antineoplastic (bone cancer)
0,124  0,023  Ornithine decarboxylase inhibitor
0,134  0,034  Pim-1 kinase inhibitor
0,104  0,004  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,122  0,022  Glutathione S-transferase inhibitor
0,167  0,067  Neurotensin receptor agonist
0,163  0,063  Interferon gamma antagonist
0,271  0,172  Transcription factor inhibitor
0,112  0,013  Maillard reaction inhibitor
0,132  0,034  Dementia treatment
0,138  0,040  Mucolytic
0,101  0,005  GABA B receptor antagonist
0,144  0,048  Cholesterol synthesis inhibitor
0,133  0,037  Mediator release inhibitor
0,105  0,010  Carbonic anhydrase XIV inhibitor
0,100  0,005  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,124  0,030  Triose-phosphate isomerase inhibitor
0,111  0,017  Narcotic antagonist
0,128  0,034  Vascular dementia treatment
0,143  0,050  Proteasome inhibitor
0,138  0,045  Sphingosine 1-phosphate receptor 4 antagonist
0,126  0,034  Anabolic
0,146  0,053  Retinoprotector
0,141  0,049  Antiprotozoal (Amoeba)
0,153  0,061  Antianemic
0,180  0,088  Abortion inducer
0,154  0,063  Movement disorders treatment
0,167  0,077  Liver fibrosis treatment
0,114  0,024  Keratolytic
0,125  0,034  GST T1-1 substrate
0,099  0,009  Estrogen receptor alpha agonist
0,111  0,021  Adenosine A3 receptor antagonist
0,118  0,029  NADH dehydrogenase inhibitor
0,131  0,042  Nav1.5 sodium channel blocker
0,111  0,023  mTOR complex 2 inhibitor
0,174  0,086  Sedative
0,097  0,010  Topoisomerase II beta inhibitor
0,157  0,070  Cytidine deaminase inhibitor
0,152  0,067  Thiol protease inhibitor
0,090  0,006  CXC chemokine 1 receptor antagonist
0,128  0,045  Expectorant
0,091  0,010  Transcription factor RelA inhibitor
0,097  0,017  Carbonic anhydrase VB inhibitor
0,085  0,005  Catechol O-methyltransferase inhibitor
0,089  0,009  Postcoital contraceptive
0,103  0,023  SULT1A2 substrate
0,153  0,073  Aldose reductase substrate
0,123  0,044  Anticataract
0,097  0,018  Protein kinase C eta inhibitor
0,126  0,048  Choleretic
0,137  0,059  Antibacterial (Helicobacter pylori)
0,092  0,013  SULT2A1 substrate
0,176  0,098  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,096  0,018  Purinergic P2X1 antagonist
0,151  0,073  Hearing loss treatment
0,121  0,043  Toll-Like receptor 4 antagonist
0,114  0,037  Carcinogenic, group 2A
0,120  0,043  Chronic obstructive bronchitis treatment
0,153  0,076  Eye irritation, high
0,156  0,080  Antihelmintic (Nematodes)
0,087  0,012  Cyclin B2 inhibitor
0,132  0,057  Antitussive
0,162  0,087  Toxic, respiratory center
0,090  0,015  Cyclin B1 inhibitor
0,085  0,011  Potassium channel Kv1.3 blocker
0,149  0,075  Phospholipase A2 inhibitor
0,089  0,015  Heat shock protein 90 beta antagonist
0,090  0,019  CDK4/cyclin D1 inhibitor
0,101  0,031  Na+ K+ transporting ATPase inhibitor
0,079  0,009  Ryanodine receptor antagonist
0,076  0,006  Arginase inhibitor
0,125  0,056  Antiprotozoal (Babesia)
0,171  0,103  Antimitotic
0,108  0,040  Arylamine N-Acetyltransferase substrate
0,082  0,014  Sphingosine kinase inhibitor
0,198  0,131  Amyotrophic lateral sclerosis treatment
0,112  0,044  Prolactin inhibitor
0,098  0,031  Glutamate decarboxylase inhibitor
0,136  0,071  Psychosexual dysfunction treatment
0,094  0,029  Leukotriene synthesis inhibitor
0,164  0,100  Anesthetic general
0,090  0,026  Leukotriene antagonist
0,145  0,082  Antinephritic
0,112  0,049  CDK2/cyclin A inhibitor
0,095  0,032  Estrogen-related receptor beta agonist
0,144  0,082  Diuretic
0,082  0,022  Glutamate (mGluR6) antagonist
0,089  0,029  Antidote, organophosphates
0,123  0,065  Contraceptive female
0,076  0,017  Cyclin B inhibitor
0,177  0,118  Antiviral (HIV)
0,097  0,039  Granulocyte macrophage colony stimulating factor agonist
0,080  0,022  Antimycoplasmal
0,113  0,056  HDL-cholesterol increasing
0,109  0,052  Antifungal (Aspergillus)
0,162  0,107  I kappa B kinase epsilon inhibitor
0,100  0,047  Potassium channel activator
0,086  0,033  Phenylalanine 4-hydroxylase inhibitor
0,089  0,036  Phosphofructokinase-1 inhibitor
0,108  0,056  Adenylate kinase inhibitor
0,071  0,021  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,065  0,017  Adenosine deaminase inhibitor
0,102  0,054  Interleukin 1 beta converting enzyme inhibitor
0,143  0,095  Uterine stimulant
0,086  0,040  GABA aminotransferase inhibitor
0,064  0,018  Squalene epoxidase inhibitor
0,052  0,007  ATP citrate lysase inhibitor
0,091  0,047  Antiviral (Trachoma)
0,052  0,009  Sodium-dependent vitamin C transporter 2 inhibitor
0,065  0,023  Dihydroorotate oxidase inhibitor
0,059  0,018  Fructose-1,6-bisphosphatase inhibitor
0,147  0,106  ATPase inhibitor
0,063  0,022  Leukotriene C antagonist
0,074  0,033  NMDA receptor glycine site agonist
0,194  0,154  CYP2D6 inhibitor
0,049  0,009  Nucleoside transporters inhibitor
0,046  0,007  Estrogen-related receptor beta antagonist
0,081  0,042  MAP kinase kinase 7 inhibitor
0,064  0,024  Leukotriene B4 antagonist
0,066  0,027  Phosphatidylinositol 3-kinase gamma inhibitor
0,092  0,054  Calcium antagonist
0,126  0,090  Farnesoid X receptor antagonist
0,050  0,014  Retinoic acid alpha receptor agonist
0,194  0,159  Gastrin inhibitor
0,050  0,016  Sphingosine kinase 1 inhibitor
0,056  0,022  Cholesterol esterase inhibitor
0,055  0,022  Carbonic anhydrase IV inhibitor
0,078  0,046  NAT1 substrate
0,078  0,046  Glutamate dehydrogenase inhibitor
0,084  0,052  Caspase 7 inhibitor
0,077  0,047  Phosphodiesterase VI inhibitor
0,218  0,188  Calcium channel activator
0,054  0,024  Glucose-6-phosphate isomerase inhibitor
0,107  0,078  Microtubule formation inhibitor
0,064  0,036  Heme oxygenase stimulant
0,136  0,109  Cystic fibrosis treatment
0,051  0,024  Purinergic P2X4 antagonist
0,093  0,067  Phosphodiesterase 6D inhibitor
0,067  0,041  Carbonic anhydrase inhibitor
0,056  0,030  Aconitate hydratase inhibitor
0,041  0,017  Sirtuin 2 inhibitor
0,089  0,066  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,054  0,031  Glucose-6-phosphate translocase inhibitor
0,061  0,038  Adenosine A1 receptor antagonist
0,066  0,043  Dopamine D1 antagonist
0,095  0,073  NAT2 substrate
0,074  0,052  Antibiotic
0,048  0,027  Neuraminidase (Influenza A) inhibitor
0,030  0,009  Dopamine D1 agonist
0,088  0,067  Restless leg syndrome treatment
0,084  0,063  Histamine N-methyltransferase inhibitor
0,029  0,009  Fructose-1,6-bisphosphatase 1 inhibitor
0,117  0,097  Antiparkinsonian, tremor relieving
0,061  0,041  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,098  0,079  5 Hydroxytryptamine 3A agonist
0,068  0,050  Anticholelithogenic
0,040  0,022  Vanilloid 3 antagonist
0,042  0,024  Cholesterol absorption inhibitor
0,056  0,039  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,043  0,026  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,040  0,023  Glutamate (mGluR8) agonist
0,047  0,031  Adenylate cyclase 1 inhibitor
0,129  0,114  Male reproductive disfunction treatment
0,043  0,028  DNA gyrase subunit A inhibitor
0,084  0,070  Antineoplastic, alkylator
0,072  0,059  Vanilloid 4 agonist
0,025  0,012  Glutamate (mGluR1a) agonist
0,114  0,102  Vanilloid 1 agonist
0,056  0,044  CDK4/cyclin D inhibitor
0,025  0,013  Estrone sulfatase inhibitor
0,073  0,061  Antitreponemal
0,067  0,055  Protein kinase C beta inhibitor
0,021  0,009  Antibiotic Anthracycline-like
0,269  0,258  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,097  0,087  Adenylate cyclase inhibitor
0,116  0,106  Cell wall synthesis inhibitor
0,022  0,012  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,038  0,029  Leukotriene C4 antagonist
0,057  0,047  Carbamoyl phosphate synthetase inhibitor
0,049  0,040  Anesthetic inhalation
0,051  0,042  Heparanase inhibitor
0,016  0,008  Antibiotic Tetracycline-like
0,055  0,048  Androgen agonist
0,061  0,054  Beta 3 adrenoreceptor antagonist
0,066  0,059  Phosphodiesterase 4D inhibitor
0,056  0,050  Cyclin D1 inhibitor
0,031  0,025  Glutamate (mGluR3) agonist
0,059  0,054  Protease 3C (Human rhinovirus) inhibitor
0,039  0,035  Leukocyte elastase inhibitor
0,035  0,031  Retinoid X receptor antagonist
0,053  0,049  Cyclin-dependent kinase 6 inhibitor
0,097  0,094  Acetylcholine release stimulant
0,025  0,021  Sodium/glucose cotransporter 2 inhibitor
0,050  0,047  Argininosuccinate synthase inhibitor
0,083  0,079  Aminopeptidase B inhibitor
0,056  0,053  Protease activated receptor antagonist
0,073  0,070  Opioid kappa receptor antagonist
0,050  0,048  DNA helicase inhibitor
0,056  0,054  NMDA receptor agonist
0,025  0,024  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,064  0,063  Secretase beta inhibitor
0,070  0,069  GABA B receptor agonist
0,020  0,020  Dopamine autoreceptor agonist

